INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 1 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $418,000 | -31.4% | 120,991 | -95.0% | 0.02% | -46.7% |
| Q3 2020 | $609,000 | -11.2% | 2,419,822 | 0.0% | 0.03% | -26.8% |
| Q2 2020 | $686,000 | +43.8% | 2,419,822 | 0.0% | 0.04% | +13.9% |
| Q1 2020 | $477,000 | -60.6% | 2,419,822 | -0.2% | 0.04% | -59.1% |
| Q4 2019 | $1,212,000 | -28.5% | 2,424,516 | 0.0% | 0.09% | -27.9% |
| Q3 2019 | $1,694,000 | -84.1% | 2,424,516 | -1.4% | 0.12% | -82.8% |
| Q2 2019 | $10,651,000 | -47.2% | 2,460,136 | -10.7% | 0.71% | -37.5% |
| Q1 2019 | $20,191,000 | -3.8% | 2,754,620 | -1.1% | 1.13% | -12.8% |
| Q4 2018 | $20,979,000 | +39.2% | 2,786,000 | -2.8% | 1.30% | +76.6% |
| Q3 2018 | $15,073,000 | +31.9% | 2,867,047 | +17.0% | 0.74% | +43.8% |
| Q2 2018 | $11,425,000 | +12.5% | 2,450,592 | +52.6% | 0.51% | -1.2% |
| Q1 2018 | $10,156,000 | +18.0% | 1,605,940 | -3.9% | 0.52% | +2.8% |
| Q4 2017 | $8,607,000 | – | 1,671,515 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |